![BGB-283, a Novel RAF Kinase and EGFR inhibitor, Displays Potent Antitumor Activity in B-RAF Mutated Colorectal Cancers]()
BGB-283, a Novel RAF Kinase and EGFR inhibitor, Displays Potent Antitumor Activity in B-RAF Mutated Colorectal CancersTang, Z.; Yuan, X.; Du, R.; Cheung, S.-H.; Zhang, G.; Wei, J.; Zhao, Y.; Feng, Y.; Peng, H.; Zhang, Y.; Du, Y.; Hu, X.; Gong, W.; Liu, Y.; Gao, Y.; Liu, Y.; Hao, R.; Li, S.; Wang, S.; Ji, J.-f.; Zhang, L.-H.; Li, S.; Sutton, D.; Wei, M.; Zhou, C.; Wang, L.; Luo, L. · Molecular Cancer Therapeutics · 2015